Description

D-Myo-Inositol, 4-o-(4-Methoxyphenyl)Methyl-1,3,5-o-Methylidyne-2,6-Bis-o-(Phenylmethyl)- is a sophisticated, multi-functionalized inositol derivative, a key intermediate in advanced organic synthesis and pharmaceutical research. This compound matters for its role in constructing complex molecular architectures, particularly in the development of novel therapeutics and bioactive molecules. It is primarily needed by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of specialized glycosides, enzyme inhibitors, and other high-value chemical entities.

Application

• Pharmaceutical Intermediate: A critical building block in the synthesis of novel drug candidates, particularly those targeting metabolic and neurological pathways.
• Glycobiology Research: Used in the study and synthesis of complex inositol phosphates and glycosylated signaling molecules.
• Chemical Biology Probes: Serves as a precursor for labeled compounds used to study enzyme mechanisms and cellular processes.
• Fine Chemical Synthesis: Employed in multi-step organic synthesis to introduce protected inositol motifs into larger, more complex structures.
• Academic & Industrial R&D: Essential for research institutions and companies developing new bioactive compounds and exploring structure-activity relationships.

Basic Information

Product Name	D-Myo-Inositol, 4-o-(4-Methoxyphenyl)Methyl-1,3,5-o-Methylidyne-2,6-Bis-o-(Phenylmethyl)-
CAS No.	196302-83-7
Molecular Formula	C29H32O8
Molecular Weight	508.56 g/mol
Synonyms	1,3,5-O-Methylidene-2,6-di-O-benzyl-4-O-(4-methoxybenzyl)-myo-inositol; 4-O-(4-Methoxybenzyl)-1,3:5,7-di-O-benzylidene-myo-inositol; 2,6-Di-O-benzyl-4-O-(4-methoxybenzyl)-1,3:5,7-di-O-methylene-myo-inositol; 1,3:5,7-Di-O-methylene-2,6-di-O-benzyl-4-O-(p-methoxybenzyl)-myo-inositol; Protected myo-Inositol derivative; D-myo-Inositol derivative CAS 196302-83-7
EINECS	Contact for details

Quality Control

Our D-Myo-Inositol derivative is produced under strict quality management protocols to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical characterization, including HPLC for purity assessment and NMR for structural confirmation. Certificates of Analysis (COA) detailing all test results are provided with every shipment. We support cGMP compliance for advanced intermediates intended for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.